GFAP and multiple sclerosis: Previous studies showed the association of brain atrophy with neuroinflammation and unspecific neurodegeneration as assessed with serum and plasma GFAP and NfL in patients with different brain diseases (i.e. traumatic brain injury, multiple sclerosis, etc.)[34–36].